MASHINIi

Enliven Therapeutics, Inc..

ELVN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule kinase inhibitors to address unmet needs in oncology. Their lead product candidate, ELVN-323, is designed as a highly selective and brain-penetrant small molecule inhibitor o...Show More

Ethical Profile

Mixed.

Not enough information to create an ethical profile.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech10
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Enliven Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on developing cancer therapies. The provided articles detail public stock offerings and the company's mission in oncology. There is no evidence in the articles to suggest that Enliven Therapeutics offers lending, insurance, or other financial services to consumers. Therefore, all KPIs related to fair money and economic opportunity are not applicable to the company's operations, as per the rubric's '0' tier definitions for non-financial entities.

Fair Pay & Worker Respect

0

The provided article does not contain specific, concrete data points for any of the KPIs related to Fair Pay & Worker Respect.

1
There is no information available regarding living wage coverage, median employee compensation (to calculate CEO pay ratio), collective bargaining share, safety incident rates, pay equity ratios, worker engagement scores, employee turnover rates, labor violation incidents, insecure contract share, or health insurance coverage for the workforce.
2

Fair Trade & Ethical Sourcing

0

The provided article focuses on the company's mission, team, and approach to drug development.

1
It does not contain any data relevant to fair trade or ethical sourcing practices, nor does it provide specific information about the company's supply chain, procurement activities, or supplier relationships.
2
Therefore, no KPIs could be assessed.
3

Honest & Fair Business

-40

The company has a whistleblower policy allowing anonymous reporting via a hotline and website, with reported violations subject to prompt and thorough investigation.

1
However, there is no explicit evidence of independent investigation processes. Six of nine directors are determined to be independent, meaning approximately 66.7% of the board is conflict-free.
2
The company has a "zero tolerance" anti-bribery and corruption policy, which mentions compliance with the U.S. Foreign Corrupt Practices Act of 1977 and the U.K. Bribery Act of 2010, but the effectiveness of training is not publicly measured.
3

Kind to Animals

0

No evidence available to assess Enliven Therapeutics, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Enliven Therapeutics, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No specific quantitative data points relevant to the 'Planet-Friendly Business' ethical value were found across the provided articles. The articles mention general business practices and ESG risk ratings but do not offer measurable facts for any of the defined KPIs.

1

Respect for Cultures & Communities

0

The provided articles do not contain any specific, concrete data points or verifiable actions for any of the KPIs related to 'Respect for Cultures & Communities'. Information about the company's operations, financial results, and internal culture is present, but there is no evidence regarding formal partnerships with community groups, reinvestment in local development, cultural incident reporting, cultural impact assessments, local employment ratios, grievance mechanisms, or any other community-focused metrics.

1
Therefore, no KPIs can be scored based on the evidence provided.

Safe & Smart Tech

10

The company states it has implemented and maintained commercially reasonable controls, policies, and safeguards for its IT systems and data, including Personal Data.

1
It reports no material breaches, violations, outages, or unauthorized uses of or accesses to its systems, except for those remedied without material cost or duty to notify.
2
The company asserts material compliance with all applicable data privacy and security laws and regulations, including HIPAA and GDPR, and confirms its internal policies and disclosures related to data privacy and security have not been inaccurate or in violation of these laws.
3
It also states it has policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data, and takes appropriate steps to ensure compliance with these policies.
4

Zero Waste & Sustainable Products

0

No evidence available to assess Enliven Therapeutics, Inc. on Zero Waste & Sustainable Products.

Own Enliven Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.